Pro: “Bridging anticoagulation is needed during warfarin interruption in patients who require elective surgery”

• References

• 1 Douketis JD, Berger PB, Dunn AS. et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl. 06) 299S-339S.
• 2 Dentali F, Pignatelli P, Malato A. et al. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Am J Hematol 2012; 87: 384-387.
• 3 Caliendo FJ, Halpern VJ, Marini C P. et al. Warfarin anticoagulation in the perioperative period: is it safe?. Ann Vasc Surg 1999; 13: 11-16.
• 4 Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003; 163: 901-908.
• 5 Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004; 164: 1319-1326.
• 6 Jaffer AK, Brotman DJ, Bash LD. et al. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. Am J Med 2006; 123: 141-150.
• 7 Spyropoulos AC, Turpie AGG, Dunn AS. et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost 2006; 04: 1246-1252.
• 8 Dunn A. Perioperative management of oral anti-coagulation: when and how to bridge. J Thromb Thrombolysis 2006; 21: 85-89.
• 9 Malato A, Saccullo G, LoCoco L. et al. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin. J Thromb Haemost 2010; 08: 107-113.
• 10 Kovacs MJ, Kearon C, Rodger M. et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004; 110: 1658-1663.
• 11 Pengo V, Cucchini U, Denas G. et al. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation 2009; 119: 2920-2927.
• 12 Spyropoulos AC, Douketis JD. Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anti-coagulation. Intern Angiol 2008; 27: 333-343.
• 13 Douketis JD, Spyropoulos AC, Spencer FA. et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl. 02) e326S-350S.
• 14 Siegal D, Judin YJ, Lim W. et al. Perioperative heparin bridging in patients receiving oral anticoagulation: meta-analysis of bleeding and thromboembolic rates. J Thromb Haemost. 2011 09. (Suppl 2): Abstract P-WE-269.
• 15 Garcia DA, Regan S, Henault LE. et al. Risk of thromboembolism with short-term interruption of warfarin therapy.[see comment]. Arch Intern Med 2008; 168: 63-69.
• 16 Douketis JD, Kearon KC, Bates S. et al. The risk of fatal pulmonary embolism in patients with treated venous thromboembolism. J Am Med Assoc 1998; 279: 458-462.
• 17 Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 2003; 139: 893-900.
• 18 Martinell J, Jimenez A, Rabago G. et al. Mechanical cardiac valve thrombosis. Is thrombectomy justified?. Circulation 1991; 84 (Suppl. 05) III70-75.
• 19 Longstreth Jr WT, Bernick C, Fitzpatrick A. et al. Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology 2001; 56: 368-375.
• 20 Spyropoulos AC, Douketis DJ, Gerotziafas G. et al. on behalf of the Subcommittee on Control of Antcoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Periporcedural antithrom-botic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. J Thromb Haemost 2012; 10: 692-694.
• 21 National Heart, Lung and Blood Institute. Effectiveness of bridging anticoagulation for surgery (The BRIDGE Study). ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). Available at: http://clinicaltrials.gov/ct2/show/NCT00786474?term=NCT00786474&rank=1NLMIdentifier:NCT00786474 Accessed January 20, 2010.
• 22 Lawson Health Research Institute. PERIOP 2 - A safety and effectiveness study of LMWH bridging therapy versus placebo bridging therapy for patients on long term warfarin and require temporary interruption of their warfarin. Clinical-Trials.gov. Bethesda (MD): National Library of Medicine (US). Available at: http://clinicaltrials.gov/ct2/show/NCT00432796?term=NCT00432796&rank=1NLMIdentifier:NCT00432796 Accessed January 21, 2010.
• 23 Healy JS, Eikelboom J, Douketis J. et al. on behalf of the RELY Invetigators. Peri-Procedural Bleeding and Thromboembolic Events with Dabigatran Compared to Warfarin: Results from the RE-LY randomized trial. Circulation. 2012 in press.
• 24 Omran H, Hammerstingl C, Schmidt H. et al. Peri-intraventionelles Management bei oral antikoagukierten Patienten. Hamostaseologie. 2005 XX: L6 [abstract].
• 25 Spyropoulos AC, Turpie AG, Dunn AS. et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost 2006; 04: 1246-1252.
• 26 Dunn AS, Spyropoulos AC, Turpie AGG. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 2007; 05: 2211-2218.
• 27 Halbritter KM, Wawer A, Beyer J. et al. Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes J Thromb Haemost 2007; 03: 2823-2825.